FREE Product of the Month October 2024
This eucalyptus is unlike any you've tried before! doTERRA blended 5 species of eucalyptus so you have the full profile of eucalyptus essential oil with consistency!
Each bottle contains essential oils from e. radiata, e. polybractea, e. kochii, e. loxophleba, and e. globulus.
The main constituent is eucalyptol and is widely studied and known for respiratory support and reducing inflammation in the lungs.
Five common uses:
diffuse or apply topically (diluted) to clear the mind
diffuse to promote relaxation (create your own home spa experience)
diffuse and apply topically (diluted) to open airways when feeling ill or before physical activity
put a drop in the bottom of your shower or make DIY shower steamers to facilitate mucus breakdown and open airways
apply topically (diluted) before dry brushing to revitalize the skin
Modern medicine is widely made from isolated compounds from nature that are then synthesized, patented and sold to the masses. But what those of us who use essential oils and other solutions straight from nature with a full profile know (not just eucalyptol that we mentioned here) is that it works effectively and efficiently. Nature knows!
This is why we invite you to experience doTERRA's eucalyptus.
For the month of October 2024, you can get eucalyptus for free with a rewards order of 125 pv (point value) placed before October 15.
The rewards program gives you points back on every purchased, based on the point value, up to 30%! All wholesale customers already enjoy 25% off of their orders, so combined with the rewards program, you receive 55% in rewards. Learn more here!
New customers can receive the Free product of the month on their first order if they choose to subscribe and save before checkout (you can edit this every month so you only get what you need.) Check with your Wellness Advocate or who introduced you to doTERRA to learn more and for help ordering. If you'd like to connect with someone from our community - click here and find someone near you!
ความคิดเห็น